The pharma industry’s reputation is getting worse. Pharmafile reports that “35.4% said that multinational pharma companies had either an ‘excellent’ or ‘good’ reputation in 2013. While this is about the same result as in 2012, it is well below 2011 when 41% of respondents gave that answer.”
Below are the 2013 reputation rankings for different healthcare industries.
- Retail pharmacists, 61.9% (had either an ‘excellent’ or ‘good’ reputation)
- Medical-device companies, 54.9%
- Healthcare services (private sector), 51.1%
- Health insurers (not-for-profit), 42.8%
- Generic drug manufacturers, 41.5%
- Biotechnology companies, 40.6%
- Multinational pharma companies, 35.4%
- Health insurers (for-profit), 26.7 per cent.
Although patients view pharmaceutical companies negatively, they view for-profit health insurers as having the worst reputation.
1 Comment